NCT00006505View on ClinicalTrials.gov

Solitary Islet Transplantation for Type 1 Diabetes Mellitus Using Steroid Sparing Immunosuppression

PHASE2CompletedINTERVENTIONAL
Enrollment

6

Participants

Timeline

Start Date

November 16, 2000

Primary Completion Date

June 30, 2002

Study Completion Date

April 21, 2020

Conditions
Diabetes Mellitus Type 1
Interventions
DRUG

Islet Transplantation

Islet cell transplantation. This study will test whether a new islet transplant procedure will enable patients with type 1 diabetes mellitus to stop insulin therapy

Trial Locations (1)

20892

National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda

All Listed Sponsors
lead

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

NIH

NCT00006505 - Solitary Islet Transplantation for Type 1 Diabetes Mellitus Using Steroid Sparing Immunosuppression | Biotech Hunter | Biotech Hunter